Regulation of Toll-like receptor signaling in the innate immunity

被引:53
作者
An HuaZhang [1 ]
Qian Cheng
Cao XueTao
机构
[1] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China
关键词
Toll-like receptors; TLR signaling; NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; I INTERFERON-PRODUCTION; NEGATIVE REGULATOR; PROINFLAMMATORY CYTOKINE; STRUCTURAL BASIS; CUTTING EDGE; INTERLEUKIN-1; RECEPTOR; SPLICE VARIANT; TIR-DOMAIN;
D O I
10.1007/s11427-010-0011-x
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Toll-like receptors sense invading pathogens by recognizing a wide variety of conserved pathogen-associated molecular patterns (PAMPs). The members of TLR family selectively utilize adaptor proteins MyD88, TRIF, TIRAP and TRAM to activate overlapping but distinct signal transduction pathways which trigger production of different panels of mediators such as proinflammatory cytokines and type I interferon. These mediators not only control innate immunity but also direct subsequently developed adaptive immunity. TLR activation is strictly and finely regulated at multiple levels of the signal transduction pathways.
引用
收藏
页码:34 / 43
页数:10
相关论文
共 95 条
[1]
Toll-like receptor signaling [J].
Akira, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38105-38108
[2]
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 [J].
An, Huazhang ;
Hou, Jin ;
Zhou, Jun ;
Zhao, Wei ;
Xu, Hongmei ;
Zheng, Yuejuan ;
Yu, Yizhi ;
Liu, Shuxun ;
Cao, Xuetao .
NATURE IMMUNOLOGY, 2008, 9 (05) :542-550
[3]
SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production [J].
An, Huazhang ;
Zhao, Wei ;
Hou, Jin ;
Zhang, Yan ;
Xie, Yun ;
Zheng, Yuejuan ;
Xu, Hongmei ;
Qian, Cheng ;
Zhou, Jun ;
Yu, Yizhi ;
Liu, Shuxun ;
Feng, Gensheng ;
Cao, Xuetao .
IMMUNITY, 2006, 25 (06) :919-928
[4]
Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells [J].
Baetz, A ;
Frey, M ;
Heeg, K ;
Dalpke, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54708-54715
[5]
Identification of the familial cylindromatosis tumour-suppressor gene [J].
Bignell, GR ;
Warren, W ;
Seal, S ;
Takahashi, M ;
Rapley, E ;
Barfoot, R ;
Green, H ;
Brown, C ;
Biggs, PJ ;
Lakhani, SR ;
Jones, C ;
Hansen, J ;
Blair, E ;
Hofmann, B ;
Siebert, R ;
Turner, G ;
Evans, DG ;
Schrander-Stumpel, C ;
Beemer, FA ;
van den Ouweland, A ;
Halley, D ;
Delpech, B ;
Cleveland, MG ;
Leigh, I ;
Leisti, J ;
Rasmussen, S ;
Wallace, MR ;
Fenske, C ;
Banerjee, P ;
Oiso, N ;
Chaggar, R ;
Merrett, S ;
Leonard, N ;
Huber, M ;
Hohl, D ;
Chapman, P ;
Burn, J ;
Swift, S ;
Smith, A ;
Ashworth, A ;
Stratton, MR .
NATURE GENETICS, 2000, 25 (02) :160-165
[6]
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[7]
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[8]
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[9]
Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein:: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling [J].
Bulut, Y ;
Faure, E ;
Thomas, L ;
Equils, O ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :987-994
[10]
Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268